The Society for Healthcare Epidemiology of America praised the $1.3 trillion omnibus spending bill President Donald Trump signed March 23 for its allocation of funds to support public health and infectious disease programs.
The spending package includes increased funds for several CDC initiatives, including efforts to combat antibiotic resistance and address emerging infectious disease threats. The spending also includes $480 million for the construction of a new CDC laboratory to support biodefense research.
"This vital funding supports nationwide efforts to coordinate and manage detection of and response to infectious diseases outbreaks and will allow these programs to remain strong and continue to ensure public safety," said Keith Kaye, MD, president of SHEA. "Because Congress has provided resources for infectious diseases research, the work in these areas can progress and continue to provide much needed insight into the prevention of and response to infectious diseases threats."
The National Institutes of Health and the Agency for Healthcare Research and Quality will also see funding increases through the spending bill.
More articles on infection control:
How machine learning models are rapidly predicting C. diff infections
Texas dental clinic may have exposed 9.5k patients to infectious diseases
University Hospitals: Fertility clinic storage tank failure likely the result of human error